Clinical improvement of renal amyloidosis in a patient with systemic-onset juvenile idiopathic arthritis who received tocilizumab treatment: a case report and literature review

AA amyloidosis treated with tocilizumab: case series and updated literature review

(2015) Alice Courties et al.   AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS

MEFV Mutations in Egyptian Children with Systemic-Onset Juvenile Idiopathic Arthritis

(2014) Hala M. Lotfy et al.   Molecular Diagnosis & Therapy

AA Amyloidosis Associated With Systemic-Onset Juvenile Idiopathic Arthritis

(2013) Abhijeet Saha et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Comparison of the clinical utility of tocilizumab and anti-TNF therapy in AA amyloidosis complicating rheumatic diseases

(2013) Yasuaki Okuda et al.   Modern Rheumatology

Pathophysiology and treatment of systemic amyloidosis

(2013) Julian D. Gillmore et al.   Nature Reviews Nephrology

Good medium-term efficacy of tocilizumab in DMARD and anti-TNF-α therapy resistant reactive amyloidosis

(2012) Markku Hakala et al.   ANNALS OF THE RHEUMATIC DISEASES

Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis

(2012) Fabrizio De Benedetti et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-term TNF-α Blockade in Patients with Amyloid A Amyloidosis Complicating Rheumatic Diseases

(2010) Antonio Fernández-Nebro et al.   AMERICAN JOURNAL OF MEDICINE

Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis

(2010) Jean D. Sipe et al.   AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS

Rapid and complete resolution of ascites and hydrothorax due to nephrotic syndrome caused by renal amyloidosis in a patient with juvenile chronic arthritis treated with adalimumab

(2009) Beata Nowak et al.   JOINT BONE SPINE

Is E148Q a Benign Polymorphism or a Disease-causing Mutation?

(2009) D. MAREK-YAGEL et al.   JOURNAL OF RHEUMATOLOGY

Clinical Remission in Patients with Systemic Juvenile Idiopathic Arthritis Treated with Anti-Tumor Necrosis Factor Agents

(2009) R. A.G. RUSSO et al.   JOURNAL OF RHEUMATOLOGY

Systemic-onset juvenile idiopathic arthritis complicated by early onset amyloidosis in a patient carrying a mutation in the MEFV gene

(2009) Luca Cantarini et al.   RHEUMATOLOGY INTERNATIONAL

Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial

(2008) Shumpei Yokota et al.   LANCET

MEFV mutations in systemic onset juvenile idiopathic arthritis

(2008) N. A. Ayaz et al.   RHEUMATOLOGY

Amyloidosis—Recent Developments

(2008) Tom Pettersson et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM